Track Fleury S.A. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Fleury S.A. FLRY3.SA Open Fleury S.A. in new tab

15.62 BRL
P/E
13.47
EPS
1.16
Yield
7.42%
Safety Score
67
P/B
1.70
ROE
11.67
Beta
0.32
Target Price
17.50 BRL
Loading chart...
Key Metrics
Earnings dateAug. 6, 2026
P/E13.47
EPS1.16
Book Value9.18
Price to Book1.70
Debt/Equity101.50
% Insiders55.372%
Growth
Revenue Growth0.10%
Earnings Growth0.12%
Estimates
Forward P/E10.82
Forward EPS1.44
Target Mean Price17.50
Dividend
Dividend Yield7.42%
Annual dividends1.21 BRL
Ex-Div. DateDec. 3, 2025
Payout83.72%
5y avg Yield4.95%

DCF Valuation

Tweak assumptions to recompute fair value for Fleury S.A. (FLRY3.SA)
Currency: BRL
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Fleury S.A. Logo Fleury S.A. Analysis (FLRY3.SA)

Brazil Health Care Official Website Stock

Is Fleury S.A. a good investment? Fleury S.A. (FLRY3.SA) is currently trading at 15.62 BRL. Market analysts have a consensus price target of 17.50 BRL. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 13.47. This relatively low multiple may signal that Fleury S.A. is undervalued compared to historical market norms.

Earnings Schedule: Fleury S.A. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 1.44.

For income investors, Fleury S.A. pays a dividend yield of 7.42%. With a payout ratio of 84%, the dividend appears to be under pressure.

Investor FAQ

Does Fleury S.A. pay a dividend?

Yes, it pays an annual dividend of 1.21 BRL (7.42% yield).

What asset class is Fleury S.A.?

Fleury S.A. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 1.16.

Company Profile

Fleury S.A., together with its subsidiaries, provides diagnostic imaging, clinical analysis, fertility, and infusions services in Brazil. It operates in two segments, Diagnostic Medicine and Integrated Medicine. The company also provides health management services, such as telemedicine; orthopedic medicine services; laboratory support; toxicological exam; preventive, integrated solutions, and clinical research in oncology; integrated solutions, research, development of processes and services in genomics; and laboratory analysis services. In addition, it operates a health platform, immunobiological drug infusion center, and ophthalmology service centers. Fleury S.A. was founded in 1926 and is headquartered in São Paulo, Brazil.

Exchange Ticker
SAO (Brazil) FLRY3.SA
Dividend Yield

7.42% (5y avg: 4.95%)

Annual Dividends

1.21 BRL

Next ex. div date

Dec. 3, 2025

Payout Ratio

83.72%

Historical Dividends
Year Total Dividends
2026 1.85 BRL
2025 1.68 BRL
2024 0.70 BRL
2023 0.43 BRL
2022 1.00 BRL
2021 0.96 BRL
2020 0.74 BRL
2019 1.01 BRL
2018 0.96 BRL
2017 0.64 BRL
2016 2.42 BRL
2015 0.10 BRL
2014 1.28 BRL
2013 0.52 BRL
2012 0.23 BRL
2011 0.20 BRL
2010 0.21 BRL

Yearly aggregated dividends

Dividends

Fleury S.A.
Dec 19, 2025 Paid
Dividend
0.89906 BRL
Fleury S.A.
Oct 03, 2025 Paid
Dividend
0.3101 BRL

Historical Split Corporate Actions

Split Date Split Ratio to 1
June 27, 2017 2.000000
June 13, 2023 1.050000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion